Apr 24, 2018 12:01 pm UTC| Business
MOUNTAIN VIEW, Calif., April 24, 2018 -- FogHorn Systems, a leading developer of “edge intelligence” software for industrial and commercial IoT applications, today announced that DAIHEN Corporation, a leading Japanese...
Nu-Med Plus Shareholders Re-Elect All 5 Directors at 2018 Shareholder Meeting
Apr 24, 2018 12:01 pm UTC| Business
SALT LAKE CITY, April 24, 2018 -- Nu-Med Plus, Inc. (OTCBB:NUMD), a medical device development company, announced that on April 10, 2018, shareholders voted to re-elect all the existing highly qualified directors,...
Foamix Pharmaceuticals First Quarter Financial Results Conference Call & Webcast Scheduled for May 9
Apr 24, 2018 12:01 pm UTC| Business
REHOVOT, Israel, and BRIDGEWATER, N.J., April 24, 2018 -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary...
MoneyTrac’s PotSaver Brand Joins San Diego Cannabis Community at Local Events
Apr 24, 2018 12:00 pm UTC| Business
SAN DIEGO, April 24, 2018 -- via OTC PR WIRE -- Global Payout Inc. (OTCPink:GOHE) (“Global”) is pleased to announce that, MoneyTrac Technology, Inc. (“MTRAC”, the “Company”), of which Global is a significant shareholder...
In-Memory Computing Summit Europe Announces Full Breakout Session Schedule
Apr 24, 2018 12:00 pm UTC| Business
FOSTER CITY, Calif., April 24, 2018 -- GridGain Systems, provider of enterprise-grade in-memory computing platform solutions based on Apache® Ignite™, today released the full breakout session schedule for the second...
Trifacta Increases Adoption Among Marketers as Solution for Faster Data Onboarding
Apr 24, 2018 12:00 pm UTC| Business
SAN FRANCISCO, April 24, 2018 -- Trifacta, the global leader in data preparation, today announced that use of its Wrangler products is increasing among marketers to onboard marketing data, with both marketing...
Intercept Pharmaceuticals Appoints Nancy Miller-Rich to Its Board of Directors
Apr 24, 2018 12:00 pm UTC| Business
NEW YORK, April 24, 2018 -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver...